Clinical Trial Update: Intercalating and Maintenance Use of Iressa Versus Chemotherapy in Selected Advanced Non Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing intercalating and maintenance use of Iressa (gefitinib) versus chemotherapy in selected advanced non-small cell lung cancer; results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• Iressa (gefitinib)

Snippet

Sponsor: Guangdong Association of Clinical Trials | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-01-27